Zobrazeno 1 - 10
of 97
pro vyhledávání: '"Michael Specka"'
Autor:
Patrik Roser, Mona Brunstein, Michael Specka, Jörg Timm, Stefan Kühnhold, Fabrizio Schifano, Udo Bonnet, Norbert Scherbaum
Publikováno v:
Harm Reduction Journal, Vol 21, Iss 1, Pp 1-10 (2024)
Abstract Background Direct acting antivirals (DAAs) as a curative treatment of hepatitis C have been available for several years and have replaced interferon-containing therapies. However, treatment rates of people who inject drugs (PWID) are declini
Externí odkaz:
https://doaj.org/article/9861bcb80e984246810b3ef275bf47ed
Autor:
Michael Specka, Tobias Kröckert, Mirko Trilling, Udo Bonnet, Fabrizio Schifano, Norbert Scherbaum
Publikováno v:
Frontiers in Psychiatry, Vol 14 (2023)
BackgroundDuring the COVID-19 pandemic we assessed to which extent patients in opioid maintenance treatment (OMT) adhere to official recommendations regarding preventive intervention strategies against COVID-19.MethodsPatients enrolled in two OMT cli
Externí odkaz:
https://doaj.org/article/7eed796ee43648debfba1860b34dd16a
Publikováno v:
Frontiers in Psychiatry, Vol 13 (2022)
BackgroundThere is a lack of benefit/harm assessments of illicit and licit psychoactive substances performed by substance-dependent users in comparison to addiction medicine experts.MethodsWe extended the analyses of substance harm/benefit assessment
Externí odkaz:
https://doaj.org/article/759a7819a2c1409699642afd1b108826
Autor:
Michael Specka, Thomas Kuhlmann, Udo Bonnet, Jürgen Sawazki, Luzia Schaaf, Stefan Kühnhold, Renate Steinert, Torsten Grigoleit, Helmut Eich, Benita Zeiske, Antje Niedersteberg, Katharina Steiner, Fabrizio Schifano, Norbert Scherbaum
Publikováno v:
Frontiers in Psychiatry, Vol 13 (2022)
IntroductionOver the last decade, the use of New/Novel Synthetic Opioids (NSO) has emerged as an increasing problem, and especially so in the USA. However, only little is known about the prevalence and history of NSO use in European heroin dependents
Externí odkaz:
https://doaj.org/article/6ab3c34bbef04c53a412d81406319d3d
Autor:
Michael Specka, Thomas Kuhlmann, Jürgen Sawazki, Udo Bonnet, Renate Steinert, Monika Cybulska-Rycicki, Helmut Eich, Benita Zeiske, Antje Niedersteberg, Luzia Schaaf, Norbert Scherbaum
Publikováno v:
Frontiers in Psychiatry, Vol 12 (2021)
Externí odkaz:
https://doaj.org/article/fc349b3472aa455988e714aa3f04f74f
Autor:
Norbert Scherbaum, Udo Bonnet, Henning Hafermann, Fabrizio Schifano, Stefan Bender, Torsten Grigoleit, Jens Kuhn, Peter Nyhuis, Ulrich W. Preuss, Gerhard Reymann, Udo Schneider, Jo Shibata, Michael Specka
Publikováno v:
Frontiers in Psychiatry, Vol 12 (2021)
Background: In response to the COVID-19-pandemic, a lockdown was established in the middle of March 2020 by the German Federal Government resulting in drastic reduction of private and professional traveling in and out of Germany with a reduction of s
Externí odkaz:
https://doaj.org/article/b6453b38cdb547b2985a2f954e4a43ae
Publikováno v:
PLoS ONE, Vol 16, Iss 1, p e0246146 (2021)
[This corrects the article DOI: 10.1371/journal.pone.0236268.].
Externí odkaz:
https://doaj.org/article/1b843158040042ababeab1dedee6dcb6
Autor:
Benedikt Bernd Claus, Michael Specka, Heath McAnally, Norbert Scherbaum, Fabrizio Schifano, Udo Bonnet
Publikováno v:
Frontiers in Psychiatry, Vol 11 (2020)
Background: For cannabis-dependent subjects, the relationship between cannabis withdrawal syndrome (CWS) severity and the urine cannabinoid concentrations are unclear; we investigated this using a commercial point-of-care (POC) enzyme immunoassay det
Externí odkaz:
https://doaj.org/article/f426cf3aa1854f20b748c4de26af97b4
Autor:
Udo Bonnet, Michael Specka, Michael Soyka, Thomas Alberti, Stefan Bender, Torsten Grigoleit, Leopold Hermle, Jörg Hilger, Thomas Hillemacher, Thomas Kuhlmann, Jens Kuhn, Christian Luckhaus, Christel Lüdecke, Jens Reimer, Udo Schneider, Welf Schroeder, Markus Stuppe, Gerhard A. Wiesbeck, Norbert Wodarz, Heath McAnally, Norbert Scherbaum
Publikováno v:
Frontiers in Psychiatry, Vol 11 (2020)
Background: Over the past 15 years, comparative assessments of psychoactive substance harms to both users and others have been compiled by addiction experts. None of these rankings however have included synthetic cannabinoids or non-opioid prescripti
Externí odkaz:
https://doaj.org/article/7abf015a18ca4396a74c9d26f0397101
Autor:
Michael Specka, Thomas Kuhlmann, Jürgen Sawazki, Udo Bonnet, Renate Steinert, Monika Cybulska-Rycicki, Helmut Eich, Benita Zeiske, Antje Niedersteberg, Luzia Schaaf, Norbert Scherbaum
Publikováno v:
Frontiers in Psychiatry, Vol 11 (2020)
BackgroundAbout 15 years ago, a diverse group of new recreational psychotropic substances began to emerge, which were marketed for example as “legal highs,” “research chemicals,” or “designer drugs.” These substances were later subsumed u
Externí odkaz:
https://doaj.org/article/6cc575750f8249c78f908a0c38ebe531